Biochemistry, Genetics and Molecular Biology
Genomics
100%
Immunity
92%
DNA Methylation
57%
T Cell
43%
Methylation
40%
Pan-cancer
40%
Oncogene
30%
Cancer Cell
28%
Phosphotransferase
26%
Kinase
26%
Long Non-Coding RNA
24%
Immune Checkpoints
24%
Epigenetics
24%
PD-L1
23%
Exome Sequencing
22%
RNA Sequence
21%
CpG Island
21%
Exome
20%
Immunocompetent Cell
20%
Messenger RNA
19%
Gene Expression
18%
Intravenous Immunoglobulin
18%
MicroRNA
17%
Next Generation Sequencing
17%
Carcinogenesis
16%
T Cell Receptor
16%
Wart Virus
16%
Aneuploidy
15%
Smoking
14%
Colon
14%
Transcriptomics
14%
Gene Mutation
13%
Tamsulosin
12%
Enhancer Region
12%
Promoter Region
12%
SOX9
11%
Transcriptome
10%
Immune Response
10%
Cancer Genomics
10%
Immunofluorescence
10%
Tumor Suppressor Protein
10%
CD8
10%
Cell Cycle
10%
Metabolic Pathway
9%
Transcription Factor
9%
BRCA1
9%
Regulatory T Cell
9%
Cell Cycle Progression
8%
Long Noncoding RNA
8%
P53
8%
Keyphrases
Tumor
82%
Cancer Genome Atlas
47%
Cancer Types
41%
Non-small Cell Lung Cancer (NSCLC)
35%
Molecular Characterization
30%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
27%
In Cancer
26%
Multiplex Immunofluorescence
23%
Pan-cancer
22%
Programmed Death-ligand 1 (PD-L1)
21%
Overall Survival
19%
Lung
18%
Lung Adenocarcinoma
18%
Immune Parameters
16%
Immune Profiling
15%
Molecular Features
15%
Aneuploidy
15%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
13%
Methylation
13%
Tumor Subtype
13%
Whole Exome Sequencing
12%
Neoadjuvant Chemotherapy
12%
Driver mutations
12%
Tumor Tissue
12%
Copy number Variation
11%
DNA Methylation (DNAm)
11%
Immune-related Genes
11%
Muscle-invasive Bladder Cancer
11%
T Cell Repertoire
11%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
11%
Malignant Cells
11%
Pan-cancer Analysis
10%
Cell Proliferation
10%
Gene Expression
10%
Tumor Protein p53 (TP53)
9%
Type-specific
9%
T-cell Receptor Repertoire
9%
TP53 mutation
9%
Intestinal Epithelium
9%
Mutational Landscape
9%
Immune Landscape
9%
Melanoma
8%
Response to Immunotherapy
8%
Functional Consequences
8%
Immune Checkpoint
8%
Oncogene
8%
Transcription Factor
8%
Immune Microenvironment
8%
Early-stage Lung Adenocarcinoma
8%
RNA Sequencing (RNA-seq)
8%
Medicine and Dentistry
Neoplasm
92%
Malignant Neoplasm
69%
Immunity
49%
The Cancer Genome Atlas
36%
Lung Adenocarcinoma
27%
Cancer Types
24%
Non Small Cell Lung Cancer
20%
Lung Cancer
18%
Next Generation Sequencing
17%
Cancer
17%
Immunofluorescence
16%
Lung
15%
Gene Expression
15%
Programmed Death-Ligand 1
14%
T Cell
14%
Exome Sequencing
13%
Somatics
13%
Adenocarcinoma
12%
Head and Neck Squamous Cell Carcinoma
11%
Cancer Cell
10%
Epidermal Growth Factor Receptor
10%
Tumor Microenvironment
9%
Overall Survival
9%
Transitional Cell Carcinoma
9%
Biological Marker
8%
Cell Population
8%
Oncology
8%
extracellular signal regulated kinase
8%
Immunotherapy
8%
Cell Signaling Pathway
8%
Surgery
7%
Cell Death
7%
Immunocompetent Cell
7%
Gene Expression Profiling
7%
Primary Tumor
7%
Image Analysis
7%
Exome
7%
Immunosuppressive Drug
6%
Squamous Cell Carcinoma
6%
DNA Methylation
6%
Neoadjuvant Chemotherapy
6%
Ras Signaling
5%
Immunoglobulin
5%
2 (5,6,7,8 Tetrahydro 5,5,8,8 Tetramethyl 2 Naphthyl)benzo[b]thiophene 6 Carboxylic Acid
5%
Melanoma
5%
Cell Cycle
5%
Tumor Initiation
5%
4 Iodo 2,5 Dimethoxyamphetamine
5%
Erlotinib
5%
Hippo Signaling
5%